Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

被引:418
作者
Videla, LA
Rodrigo, R
Orellana, M
Fernandez, V
Tapia, G
Quiñones, L
Varela, N
Contreras, J
Lazarte, R
Csendes, A
Rojas, J
Maluenda, F
Burdiles, P
Diaz, JC
Smok, G
Thielemann, L
Poniachik, J
机构
[1] Univ Chile, Mol & Clin Pharmacol Program, Inst Biomed Sci, Fac Med, Santiago 7, Chile
[2] Univ Chile, Clin Hosp, Dept Med, Santiago 7, Chile
[3] Univ Chile, Clin Hosp, Dept Surg, Santiago 7, Chile
[4] Univ Chile, Clin Hosp, Dept Pathol Anat, Santiago 7, Chile
[5] Univ Chile, Fac Med, Pathophysiol Program, Inst Biomed Sci, Santiago 7, Chile
关键词
non-alcoholic fatty liver disease; oxidative stress; steatohepatitis; steatosis;
D O I
10.1042/CS20030285
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oxidative stress is implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). In the present study, hepatic and plasma oxidative stress-related parameters were measured and correlated with clinical and histological findings in 31 NAFLD patients showing increased body mass index. Liver protein carbonyl content was enhanced by 403 % in patients with steatosis (n = 15) compared with control values (n = 12), whereas glutathione content, superoxide dismutase (SOD) activity and the ferric reducing ability of plasma (FRAP) were decreased by 57 %, 48 % and 2 1 % (P < 0.05) respectively. No changes in microsomal p-nitrophenol hydroxylation and the total content of cytochrome P450 (CYP) or CYP2EI were observed. Patients with steatohepatitis (n = 16) exhibited protein carbonyl content comparable with that of controls, whereas glutathione content, SOD and catalase activities were decreased by 27%, 64% and 48% (P<0.05). In addition, FRAP values in patients with steatohepatitis were reduced by 33 % and 15 % (P < 0.05) when compared with controls and patients with steatosis respectively, whereas p-nitrophenol hydroxylation (52 %) and CYP2EI content (142 %) were significantly increased (P < 0.05) compared with controls. It is concluded that oxidative stress is developed in the liver of NAFLD patients with steatosis and is exacerbated further in patients with steatohepatitis, which is associated with CYP2EI induction. Substantial protein oxidation is followed by proteolysis of the modified proteins, which may explain the co-existence of a diminished antioxidant capacity and protein oxidation in the liver of patients with steatohepatitis.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 56 条
[1]  
Aebi H., 1974, Methods in Enzymatic Analysis, V2, P674, DOI [DOI 10.1016/B978-0-12-091302-2.50032-3, 10.1016/B978-0-12-091302-2.50032-3]
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[5]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[6]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[7]   Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis [J].
Bonkovsky, HL ;
Jawaid, Q ;
Tortorelli, K ;
LeClair, P ;
Cobb, J ;
Lambrecht, RW ;
Banner, BF .
JOURNAL OF HEPATOLOGY, 1999, 31 (03) :421-429
[8]   REDUCTION AND INACTIVATION OF SUPEROXIDE-DISMUTASE BY HYDROGEN-PEROXIDE [J].
BRAY, RC ;
COCKLE, SA ;
FIELDEN, EM ;
ROBERTS, PB ;
ROTILIO, G ;
CALABRESE, L .
BIOCHEMICAL JOURNAL, 1974, 139 (01) :43-48
[9]   Hepatic cytochrome p450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis [J].
Chalasani, N ;
Gorski, JC ;
Asghar, MS ;
Asghar, A ;
Foresman, B ;
Hall, SD ;
Crabb, DW .
HEPATOLOGY, 2003, 37 (03) :544-550
[10]   Hepatic cytochrome P450 regulation in disease states [J].
Cheng, PY ;
Morgan, ET .
CURRENT DRUG METABOLISM, 2001, 2 (02) :165-183